Acta Pharmacologica Sinica

Springer Nature

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Acta Pharmacologica Sinica is a journal published by Springer Nature in United Kingdom. It is listed in MEDLINE according to the sources read. Declared publication charge: 3,990 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Nature
ISSN
1671-4083 · 1745-7254
Country
United Kingdom
Access
Not open access / not declared
Declared publication charge
3,990 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2000-01-01
Indexing
MEDLINE
APC
3,990 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
140 days received→accepted — computed from PubMed (n=95)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

4553

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

145

i10-index

3389

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
95%
ORCID iDs in current deposits
3%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity4
Alternate titles
Zhongguo yaoli xuebaoAPS
Source type
journal
NLM unique ID (PubMed)
100956087
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Autophagy in Disease and Therapy
  • Autophagy in Disease and Therapy
  • Neuroscience and Neuropharmacology Research
  • Neuroscience and Neuropharmacology Research
  • Ion channel regulation and function
  • Ion channel regulation and function
  • Receptor Mechanisms and Signaling
  • Receptor Mechanisms and Signaling
Show all subjects (50)
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Traditional Chinese Medicine Analysis
  • Traditional Chinese Medicine Analysis
  • Cell death mechanisms and regulation
  • Cell death mechanisms and regulation
  • Cardiac electrophysiology and arrhythmias
  • Cardiac electrophysiology and arrhythmias
  • Cancer, Hypoxia, and Metabolism
  • Drug Transport and Resistance Mechanisms
  • Drug Transport and Resistance Mechanisms
  • Ubiquitin and proteasome pathways
  • Cancer, Hypoxia, and Metabolism
  • Ubiquitin and proteasome pathways
  • Neuropeptides and Animal Physiology
  • Neuropeptides and Animal Physiology
  • Neurotransmitter Receptor Influence on Behavior
  • Neurotransmitter Receptor Influence on Behavior
  • Liver Disease Diagnosis and Treatment
  • Liver Disease Diagnosis and Treatment
  • Immune Response and Inflammation
  • Immune Response and Inflammation
  • Nitric Oxide and Endothelin Effects
  • Nicotinic Acetylcholine Receptors Study
  • Nitric Oxide and Endothelin Effects
  • Cardiac Ischemia and Reperfusion
  • Cardiac Ischemia and Reperfusion
  • Nicotinic Acetylcholine Receptors Study
  • Endoplasmic Reticulum Stress and Disease
  • Endoplasmic Reticulum Stress and Disease
  • MicroRNA in disease regulation
  • Inflammasome and immune disorders
  • Inflammasome and immune disorders
  • MicroRNA in disease regulation
  • Pharmacogenetics and Drug Metabolism
  • Pharmacogenetics and Drug Metabolism
  • Computational Drug Discovery Methods
  • Cardiac Fibrosis and Remodeling
  • Protein Kinase Regulation and GTPase Signaling
  • Computational Drug Discovery Methods
  • Cardiac Fibrosis and Remodeling
  • Protein Kinase Regulation and GTPase Signaling

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: